Report Categories
View AllRecent Articles
View All
Stem STEM Stock Extra Dividend Extends Gains 20260420
AXIL Brands AXIL drops 195 following Q1 2025 earnings report with negative 002 earnings per share
WYY WidePoint Corporation stock jumps 87 despite deeper quarterly loss defying expectations after earnings miss
KEQU Kewaunee posts Q1 2026 EPS of 028 dollars shares remain flat following quarterly earnings release
DexCom Inc DXCM Valuation Disparity Widens Amid ShortTerm Price Weakness And LongTerm Growth Catalysts
PPG Industries PPG Valuation Dislocation Amid Choppy NearTerm Share Price Performance
General Motors Company GM Q1 2026 Earnings Preview Key Metrics Peer Benchmarks and Investor Expectations
Is Phio Pharmaceuticals PHIO stock forming a trend channel Q4 2025 EPS Tops Views
iShares Latin America 40 ETF ILF Outperforms Broader US Equities Amid Macro Rotation and LatAm Trade Tailwinds
Jim Cramer Advises Trimming Positions in Volatile AI Chipmaker
PPL PPLC Stock Consolidating at 4825 Next Move Ahead 20260514
TrumpXi Agree on Strait of Hormuz Implications for Global Oil Shipping and Geopolitical Stability
Wholesale Inflation Surges 6 in April Marking Sharpest Annual Gain Since 2022
Univest UVSP Delivers Q1 2026 Beat EPS 098 vs 085 Expected
Tether Acquires SoftBanks Stake in Bitcoin Firm Twenty One as Company Charts Next Growth Phase
Spotify Stock Rises on Optimistic Guidance at First Investor Day Since 2022
Northwest NWN Trading at 5005 Key Decision Point 20260520
ADC Therapeutics Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues
Stryker Corporation SYK Q1 2026 Earnings EPS Misses Estimates by 1375 Amid Market Headwinds
Bowman Consulting Group Ltd BWMN Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Challenging Quarter
ACNT Q1 2025 Earnings EPS Misses Estimates Amid Market Challenges
VTSI Q1 2026 Earnings EPS Surprises Slightly Above Estimates Despite Stock Decline
NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support
Charter Communications CHTR Falls 255 as Selling Pressure Persists Near 145
Gain Therapeutics GANX Edges Higher as Biotech Sector Shows Mixed Signals
WVVIP Preferred Stock Holds Steady at 267 as Support and Resistance Levels Solidify